|
1
|
Winter-Roach B, Hooper L and Kitchener H:
Systematic review of adjuvant therapy for early stage (epithelial)
ovarian cancer. Int J Gynecol Cancer. 13:395–404. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wolpin BM, Meyerhardt JA, Mamon HJ and
Mayer RJ: Adjuvant treatment of colorectal cancer. CA Cancer J
Clin. 57:168–185. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macdonald JS, Smalley SR, Benedetti J,
Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA,
Gunderson LL, Jessup JM and Martenson JA: Chemoradiotherapy after
surgery compared with surgery alone for adenocarcinoma of the
stomach or gastroesophageal junction. New Engl J Med. 345:725–730.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liao WC, Chien KL, Lin YL, Wu MS, Lin JT,
Wang HP and Tu YK: Adjuvant treatments for resected pancreatic
adenocar-cinoma: a systematic review and network meta-analysis.
Lancet Oncol. 14:1095–1103. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wirth T, Parker N and Ylä-Herttuala S:
History of gene therapy. Gene. 525:162–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parums DV: Current status of targeted
therapy in non-small cell lung cancer. Drugs Today (Barc).
50:503–525. 2014. View Article : Google Scholar
|
|
7
|
Pan MH and Ho CT: Chemopreventive effects
of natural dietary compounds on cancer development. Chem Soc Rev.
37:2558–2574. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kannaiyan R, Shanmugam MK and Sethi G:
Molecular targets of celastrol derived from Thunder of God Vine:
potential role in the treatment of inflammatory disorders and
cancer. Cancer Lett. 303:9–20. 2011. View Article : Google Scholar
|
|
9
|
Yu J, Liu H, Lei J, Tan W, Hu X and Zou G:
Antitumor activity of chloroform fraction of Scutellaria barbata
and its active constituents. Phytotherapy Res. 21:817–822. 2007.
View Article : Google Scholar
|
|
10
|
Harhaji Lj, Mijatović S, Maksimović-Ivanić
D, Stojanović I, Momcilović M, Maksimović V, Tufegdzić S,
Marjanović Z, Mostarica-Stojković M, Vucinić Z, et al: Anti-tumor
effect of Coriolus versicolor methanol extract against mouse B16
melanoma cells: in vitro and in vivo study. Food Chem Toxicol.
46:1825–1833. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rashid S, Unyayar A, Mazmanci MA, McKeown
SR, Banat IM and Worthington J: A study of anti-cancer effects of
Funalia trogii in vitro and in vivo. Food Chem Toxicol.
49:1477–1483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCulloch M, See C, Shu XJ, Broffman M,
Kramer A, Fan WY, Gao J, Lieb W, Shieh K and Colford JM Jr:
Astragalus-based Chinese herbs and platinum-based chemotherapy for
advanced non-small-cell lung cancer: meta-analysis of randomized
trials. J Clin Oncol. 24:419–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li LX, Ye SL, Wang YH and Tang ZZ:
Progress on experimental research and clinical application of
Trametes robiniophila. Bull Chin Cancer. 16:110–113. 2007.
|
|
14
|
Wang X, Zhang N, Huo Q and Yang Q:
Anti-angiogenic and antitumor activities of Huaier aqueous extract.
Oncol Rep. 28:1167–1175. 2012.PubMed/NCBI
|
|
15
|
Wu T, Chen W, Liu S, Lu H, Wang H, Kong D,
Huang X, Kong Q, Ning Y and Lu Z: Huaier suppresses proliferation
and induces apoptosis in human pulmonary cancer cells via
upregulation of miR-26b-5p. FEBS Lett. 588:2107–2114. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Y, Sun T, Wang F, Zhang J, Li C, Chen
X, Li Q and Sun S: A polysaccharide from the fungi of Huaier
exhibits anti-tumor potential and immunomodulatory effects.
Carbohydr Polym. 92:577–582. 2013. View Article : Google Scholar
|
|
17
|
Yan X, Lyu T, Jia N, Yu Y, Hua K and Feng
W: Huaier aqueous extract inhibits ovarian cancer cell motility via
the AKT/GSK3beta/beta-catenin pathway. PloS One. 8:e637312013.
View Article : Google Scholar
|
|
18
|
Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y,
Hao M, Sheng S, Sun Y, Zhang H, et al: Astrocyte elevated gene-1
(AEG-1) shRNA sensitizes Huaier polysaccharide (HP)-induced
anti-metastatic potency via inactivating downstream P13K/Akt
pathway as well as augmenting cell-mediated immune response. Tumour
Biol. 35:4219–4224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang N, Kong X, Yan S, Yuan C and Yang Q:
Huaier aqueous extract inhibits proliferation of breast cancer
cells by inducing apoptosis. Cancer Sci. 101:2375–2383. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang F, Zhang Z and Liu Z: Effects of
Huaier aqueous extract on proliferation and apoptosis in the
melanoma cell line A875. Acta Histochem. 115:705–711. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng J, Li C, Wu X, Liu M, Sun X, Yang Y,
Hao M, Sheng S, Sun Y, Zhang H, et al: Huaier polysaccharides
suppresses hepatocarcinoma MHCC97-H cell metastasis via
inactivation of EMT and AEG-1 pathway. Int J Biol Macromol.
64:106–110. 2014. View Article : Google Scholar
|
|
22
|
Pflaum J, Schlosser S and Müller M: p53
Family and cellular stress responses in cancer. Front Oncol.
4:2852014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Advani AS, Mahfouz RZ, Maciejewski J,
Rybicki L, Sekeres M, Tripp B, Kalaycio M, Bates J and
Saunthararajah Y: Ribosomal S6 kinase and AKT phosphorylation as
pharmacodynamic biomarkers in patients with myelodysplastic
syndrome treated with RAD001. Clin Lymphoma Myeloma Leuk.
14:172–177. 2014. View Article : Google Scholar
|
|
24
|
Magnuson B, Ekim B and Fingar DC:
Regulation and function of ribosomal protein S6 kinase (S6K) within
mTOR signalling networks. Biochem J. 441:1–21. 2012. View Article : Google Scholar
|
|
25
|
Hedden A, Müller V and Jensen EV: A new
interpretation of antiestrogen action. Ann NY Acad Sci.
761:109–120. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klinge CM: Estrogen receptor interaction
with estrogen response elements. Nucleic Acids Res. 29:2905–2919.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Zhang N, Huo Q, Sun M, Lv S and
Yang Q: Huaier aqueous extract suppresses human breast cancer cell
proliferation through inhibition of estrogen receptor α signaling.
Int J Oncol. 43:321–328. 2013.PubMed/NCBI
|
|
28
|
Shen HM and Tergaonkar V: NFkappaB
signaling in carcinogenesis and as a potential molecular target for
cancer therapy. Apoptosis. 14:348–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barker N and Clevers H: Mining the Wnt
pathway for cancer therapeutics. Nat Rev Drug Discov. 5:997–1014.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Cao XX, Chen Q, Zhu TF, Zhu HG and
Zheng L: DIXDC1 targets p21 and cyclin D1 via PI3K pathway
activation to promote colon cancer cell proliferation. Cancer Sci.
100:1801–1808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin X, Zhu Z and Shi Y: Metastasis
mechanism and gene/protein expression in gastric cancer with
distant organ metastasis. Bull Cancer. Oct 8–2014.Epub ahead of
print.
|
|
33
|
Song IH: Cancer metastasis and metastasis
suppressors. Korean J Gastroenterol. 43:1–7. 2004.In Korean.
PubMed/NCBI
|
|
34
|
Grinshpun A, Ben-Porath I, Peretz T and
Salmon A: Tumor, metastasis and what’s in between. Harefuah.
152:30–33. 59582013.
|
|
35
|
Bajpai S, Feng Y, Wirtz D and Longmore GD:
β-Catenin serves as a clutch between low and high intercellular
E-cadherin bond strengths. Biophys J. 105:2289–2300. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Xu GH, Wang K, Cao JL, Gu EW, Li YH
and Liu XS: Involvement of GSK3β/β-catenin signaling in the
impairment effect of ketamine on spatial memory consolidation in
rats. Neurobiol Learn Mem. 111:26–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yuan L, Shi RR, Rao SM, Song JL and Cui
MC: Reversal of resistance to adriamycin in human breast cancer
cell line MCF-7/ADM by silencing AEG-1 gene and its mechanism.
Sheng Li Xue Bao. 66:625–630. 2014.In Chinese. PubMed/NCBI
|
|
38
|
Ke ZF, Mao X, Zeng C, He S, Li S and Wang
LT: AEG-1 expression characteristics in human non-small cell lung
cancer and its relationship with apoptosis. Med Oncol. 30:3832013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tassi E and Wellstein A: Tumor
angiogenesis: initiation and targeting – therapeutic targeting of
an FGF-binding protein, an angiogenic switch molecule, and
indicator of early stages of gastrointestinal adenocarcinomas.
Cancer Res Treat. 38:189–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonapace L, Coissieux MM, Wyckoff J, Mertz
KD, Varga Z, Junt T and Bentires-Alj M: Cessation of CCL2
inhibition accelerates breast cancer metastasis by promoting
angiogenesis. Nature. 515:130–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Phoophitphong T, Hanprasertpong J,
Dechsukhum C and Geater A: Correlation of angiogenesis and
recurrence-free survival of early stage cervical cancer patients
undergoing radical hysterectomy with pelvic lymph node dissection.
J Obstet Gynaecol Res. 33:840–848. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tang HS, Feng YJ and Yao LQ: Angiogenesis,
vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J
Gynecol Cancer. 19:605–610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Giuliano S and Pagès G: Mechanisms of
resistance to anti-angiogenesis therapies. Biochimie. 95:1110–1119.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Neufeld G, Cohen T, Gengrinovitch S and
Poltorak Z: Vascular endothelial growth factor (VEGF) and its
receptors. FASEB J. 13:9–22. 1999.PubMed/NCBI
|
|
50
|
Paley PJ, Staskus KA, Gebhard K, Mohanraj
D, Twiggs LB, Carson LF and Ramakrishnan S: Vascular endothelial
growth factor expression in early stage ovarian carcinoma. Cancer.
80:98–106. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen P, Zhu J, Liu DY, Li HY, Xu N and Hou
M: Overexpression of survivin and VEGF in small-cell lung cancer
may predict the poorer prognosis. Med Oncol. 31:7752014. View Article : Google Scholar
|
|
52
|
Ren J, Zheng C, Feng G, Liang H, Xia X,
Fang J, Duan X and Zhao H: Inhibitory effect of extract of fungi of
Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci
Technolog Med Sci. 29:198–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wyllie AH, Kerr JF and Currie AR: Cell
death: the significance of apoptosis. Int Rev Cytol. 68:251–306.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Adams JM and Cory S: The Bcl-2 apoptotic
switch in cancer development and therapy. Oncogene. 26:1324–1337.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lowe SW and Lin AW: Apoptosis in cancer.
Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Green DR, Galluzzi L and Kroemer G: Cell
biology. Metabolic control of cell death. Science. 345:12502562014.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Degli Esposti M: Mitochondria in
apoptosis: past, present and future. Biochem Soc Trans. 32:493–495.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Costa M, Costa-Rodrigues J, Fernandes MH,
Barros P, Vasconcelos V and Martins R: Marine cyanobacteria
compounds with anticancer properties: a review on the implication
of apoptosis. Mar Drugs. 10:2181–2207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB
and Cheng XC: MicroRNA-21 gene and cancer. Med Oncol. 30:3762013.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Solomides CC, Evans BJ, Navenot JM,
Vadigepalli R, Peiper SC and Wang ZX: MicroRNA profiling in lung
cancer reveals new molecular markers for diagnosis. Acta Cytol.
56:645–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX,
Cao DX, He M, Chen GQ, He JR and Zhao Q: MicroRNA-26b is
underexpressed in human breast cancer and induces cell apoptosis by
targeting SLC7A11. FEBS Lett. 585:1363–1367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Koh CM, Iwata T, Zheng Q, Bethel C,
Yegnasubramanian S and De Marzo AM: Myc enforces overexpression of
EZH2 in early prostatic neoplasia via transcriptional and
post-transcriptional mechanisms. Oncotarget. 2:669–683.
2011.PubMed/NCBI
|
|
63
|
Yuan JB, Yang LY, Tang ZY, Zu XB and Qi L:
Down-regulation of EZH2 by RNA interference inhibits proliferation
and invasion of ACHN cells via the Wnt/β-catenin pathway. Asian Pac
J Cancer Prev. 13:6197–6201. 2012. View Article : Google Scholar
|
|
64
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar
|
|
66
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
67
|
Rycaj K and Tang DG: Cancer stem cells and
radioresistance. Int J Radiat Biol. 90:615–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen K, Huang YH and Chen JL:
Understanding and targeting cancer stem cells: therapeutic
implications and challenges. Acta Pharmacol Sin. 34:732–740. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Beier D, Schulz JB and Beier CP:
Chemoresistance of glioblastoma cancer stem cells--much more
complex than expected. Mol Cancer. 10:1282011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Tsujii M: Cancer therapy targeting cancer
stem cell. Nihon rinsho. 72:35–41. 2014.In Japanese. PubMed/NCBI
|
|
71
|
Bao B, Li Y, Ahmad A, Azmi AS, Bao G, Ali
S, Banerjee S, Kong D and Sarkar FH: Targeting CSC-related miRNAs
for cancer therapy by natural agents. Curr Drug Targets.
13:1858–1868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhang T1, Wang K, Zhang J, Wang X, Chen Z,
Ni C, Qiu F and Huang J: Huaier aqueous extract inhibits colorectal
cancer stem cell growth partially via downregulation of the
Wnt/β-catenin pathway. Oncol Lett. 5:1171–1176. 2013.PubMed/NCBI
|
|
73
|
Wang X, Zhang N, Huo Q, Sun M, Dong L,
Zhang Y, Xu G and Yang Q: Huaier aqueous extract inhibits stem-like
characteristics of MCF7 breast cancer cells via inactivation of
hedgehog pathway. Tumour Biol. 35:10805–10813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Gangopadhyay S, Nandy A, Hor P and
Mukhopadhyay A: Breast cancer stem cells: a novel therapeutic
target. Clin Breast Cancer. 13:7–15. 2013. View Article : Google Scholar
|
|
76
|
Townsend KN, Hughson LR, Schlie K, Poon
VI, Westerback A and Lum JJ: Autophagy inhibition in cancer
therapy: metabolic considerations for antitumor immunity. Immunol
Rev. 249:176–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ladányi A and Balatoni T: Unblocking
antitumor immune response: novel possibilities for the
immunotherapy of melanoma. Magy Onkol. 57:100–107. 2013.In
Hungarian.
|
|
78
|
Li C, Wu X, Zhang H, Yang G, Hao M, Sheng
S, Sun Y, Long J, Hu C, Sun X, et al: A Huaier polysaccharide
inhibits hepatocel-lular carcinoma growth and metastasis. Tumour
Biol. Nov 6–2014.Epub ahead of print.
|
|
79
|
Stuelp-Campelo PM, de Oliveira MB, Leão
AM, Carbonero ER, Gorin PA and Iacomini M: Effect of a soluble
alpha-D-glucan from the lichenized fungus Ramalina celastri on
macrophage activity. Int Immunopharmacol. 2:691–698. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Fidler IJ and Kleinerman ES: Therapy of
cancer metastasis by systemic activation of macrophages: from the
bench to the clinic. Res Immunol. 144:284–287. 1993. View Article : Google Scholar : PubMed/NCBI
|
